Press Releases
Page 3 • 12 itemsAccess critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Amgen Reports Strong Q1 2026 Financial Results with 16 Brands Achieving Double-Digit Growth
Amgen's Q1 2026 results show robust performance with 16 brands posting double-digit growth, offsetting patent expirations and increased competition.
Haier Biomedical Reports Record 36% International Revenue Growth in Life Science Infrastructure Market
Haier Biomedical achieves 36% international revenue share with $340.77M total revenue, driving AI-powered life science infrastructure expansion globally.
Genprex Receives Israel Patent for Reqorsa Gene Therapy Combined with PD-1 Antibodies in Cancer Treatment
Genprex secures Israeli patent protection for Reqorsa gene therapy combination with PD-1 antibodies, strengthening intellectual property portfolio for cancer treatment.
Prolacta's Human Milk-Based Fortifiers Receive World's First Prescription Drug Status in Japan Following JASMINE Trial Success
Prolacta achieves global regulatory milestone as Japan grants prescription drug status to human milk-based fortifiers for premature infants based on JASMINE trial data.
Axoft Raises $55M Series A to Advance Brain-Computer Interface Clinical Trials Globally
Axoft secures $55M Series A funding led by C.P. Group Innovation to advance bio-inspired brain-computer interface technology into global clinical trials.
Vivacta Bio Raises $50M+ Series A Funding for GT801 CAR-T Gene Therapy Development
Vivacta Biotechnology closes $50M+ Series A funding to advance GT801, an innovative in vivo CAR-T therapy for blood cancers and autoimmune diseases.
Taimei Technology Debuts AI-Powered Clinical Trial Platform at BioKorea 2026
Taimei Technology showcases AI-driven drug development platform at BioKorea 2026, planning Korea market entry with advanced clinical research solutions.
Energenesis Biomedical ENERGI-F703DFU Diabetic Foot Ulcer Treatment Data to Be Presented at EWMA 2026
Energenesis Biomedical will present clinical data for ENERGI-F703DFU gel, a novel topical treatment for diabetic foot ulcers, at EWMA 2026 in Bremen.
Ascletis Pharma to Present Diabetes Drug Data at American Diabetes Association 2026 Scientific Sessions
Ascletis Pharma will present clinical data on multiple diabetes programs at the ADA 2026 Scientific Sessions, showcasing pipeline developments in diabetes treatment.
TLX597-Tx PSMA Radioligand Therapy Shows Promise in OPTIMAL-PSMA Trial for Early-Stage Prostate Cancer
TLX597-Tx radioligand therapy demonstrates low organ toxicity in OPTIMAL-PSMA trial, potentially enabling dose intensification for prostate cancer treatment.
ImmunityBio Faces Securities Fraud Lawsuit Over Anktiva Off-Label Promotion After FDA Warning Letter
ImmunityBio hit with class action lawsuit after FDA determined company made false claims about Anktiva bladder cancer drug's capabilities beyond approved use.
Insilico Medicine's Rentosertib Inhalation Solution Receives IND Clearance for First AI-Driven Direct-to-Lung Clinical Trial
Insilico Medicine's AI-discovered Rentosertib inhalation solution gets IND clearance for direct-to-lung delivery, marking a milestone in AI drug development.